Liqian Mo
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Xiaoyan Xiao (6 shared papers)Yongyi Ye (1 shared paper)Chun‐Nan Lin (1 shared paper)Guohui Lu (1 shared paper)Xiaozheng He (1 shared paper)Qifu Wang (1 shared paper)Zhiyuan Zhu (1 shared paper)Haoyuan Wang (1 shared paper)
- Journals
- Drug Design Development and Therapy (2 papers)Frontiers in Pharmacology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Functional Foods (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- China
In The Last Decade
Liqian Mo
21 papers receiving 422 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 106
- Complementary and alternative medicine 29
- Nephrology 23
- Biological Psychiatry 7
- Molecular Biology 205
Countries citing papers authored by Liqian Mo
This map shows the geographic impact of Liqian Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqian Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqian Mo more than expected).
Fields of papers citing papers by Liqian Mo
This network shows the impact of papers produced by Liqian Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqian Mo. The network helps show where Liqian Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Liqian Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 167 | |
| 2 | 2017 | 58 | |
| 3 | 2012 | 35 | |
| 4 | 2014 | 27 | |
| 5 | 2016 | 27 | |
| 6 | 2021 | 25 | |
| 7 | 2015 | 17 | |
| 8 | 2014 | 14 | |
| 9 | 2022 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2017 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2017 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 2 | |
| 19 | [Compound Huang Gan delays chronic renal failure after 5/6 nephrectomy in rats]. | 2014 | 1 |
| 20 | 2023 | 1 |
About Liqian Mo
Liqian Mo is a scholar working on Molecular Biology, Pharmacology, Nephrology, Pediatrics, Perinatology and Child Health and Oncology, having authored 24 papers that have together received 425 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Advanced Glycation End Products research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Dialysis and Renal Disease Management (2 papers) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Cancer Research (106 citations), Complementary and alternative medicine (29 citations), Nephrology (23 citations), Biological Psychiatry (7 citations) and Molecular Biology (205 citations). Liqian Mo has collaborated with scholars based in China. Frequent co-authors include Xiaoyan Xiao, Yongyi Ye, Chun‐Nan Lin, Guohui Lu, Xiaozheng He, Qifu Wang, Zhiyuan Zhu, Haoyuan Wang, Huiqing Wang and Shizhong Zhang. Their work appears in journals such as Drug Design Development and Therapy, Frontiers in Pharmacology, Biochemical and Biophysical Research Communications, Journal of Functional Foods and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.